BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-272@pharmaconomics
DTSTAMP:20260707T030402Z
DTSTART;VALUE=DATE:20250402
DTEND;VALUE=DATE:20250403
SUMMARY:ALDX PDUFA — reproxalap
DESCRIPTION:The FDA's approval decision on reproxalap for dry eye disease is due Apr 2\, 2025. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1341235/000119312526109511/aldx-20260317.htm\n\nTrack it: https://pharmaconomics.com/e/272
URL:https://pharmaconomics.com/e/272
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ALDX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR